Free Trial
Jeff Cohen

Jeff Cohen Analyst Performance

Director of Research at LADENBURG THALM/SH SH

Jeff Cohen is a stock analyst at LADENBURG THALM/SH SH focused in the medical sector, covering 8 publicly traded companies. Over the past year, Jeff Cohen has issued 3 stock ratings, including buy and hold recommendations. While full access to Jeff Cohen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jeff Cohen's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
12 Last 7 Years
Buy Recommendations
66.67% 8 Buy Ratings
Companies Covered
8 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%8 ratings
Hold33.3%4 ratings
Sell0.0%0 ratings

Out of 12 total stock ratings issued by Jeff Cohen at LADENBURG THALM/SH SH, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
87.5% of companies on NASDAQ
7 companies
NYSE
12.5% of companies on NYSE
1 company

Jeff Cohen, an analyst at LADENBURG THALM/SH SH, currently covers 8 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
62.5%
Consumer Discretionary
3 companies
37.5%

Jeff Cohen of LADENBURG THALM/SH SH specializes in stock coverage within the Medical sector, with additional focus on Consumer Discretionary companies.

Coverage Industries

IndustryPercentage
GAMING
3 companies
37.5%
MED INSTRUMENTS
2 companies
25.0%
MED - DRUGS
1 company
12.5%
MEDICAL SERVICES
1 company
12.5%
MED PRODUCTS
1 company
12.5%

Jeff Cohen's Ratings History at LADENBURG THALM/SH SH

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Artivion, Inc. stock logo
AORT
Artivion
4/10/2026Upgrade$36.54$42.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
8/28/2025Initiated Coverage$0.99$3.60Buy
Artivion, Inc. stock logo
AORT
Artivion
8/13/2025Downgrade$43.71$38.80Neutral
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
5/5/2025Initiated Coverage$3.75$8.70Buy
CeriBell, Inc. stock logo
CBLL
CeriBell
4/4/2025Initiated Coverage$18.73$32.00Buy
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2/20/2025Initiated Coverage$21.81$20.00Neutral